These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 15161436
1. Adult T-cell leukemia: future prophylaxis and immunotherapy. Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Masuda M. Expert Rev Anticancer Ther; 2004 Jun; 4(3):369-76. PubMed ID: 15161436 [Abstract] [Full Text] [Related]
2. Immunological risks of adult T-cell leukemia at primary HTLV-I infection. Kannagi M, Ohashi T, Harashima N, Hanabuchi S, Hasegawa A. Trends Microbiol; 2004 Jul; 12(7):346-52. PubMed ID: 15223062 [Abstract] [Full Text] [Related]
3. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors. Kitazono T, Okazaki T, Araya N, Yamano Y, Yamada Y, Nakamura T, Tanaka Y, Inoue M, Ozaki S. Cell Immunol; 2011 Jul; 272(1):11-7. PubMed ID: 22030472 [Abstract] [Full Text] [Related]
4. Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant. Kozako T, Hirata S, Shimizu Y, Satoh Y, Yoshimitsu M, White Y, Lemonnier F, Shimeno H, Soeda S, Arima N. FEBS J; 2011 Apr; 278(8):1358-66. PubMed ID: 21332943 [Abstract] [Full Text] [Related]
5. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection. Simpson RM, Zhao TM, Hubbard BS, Sawasdikosol S, Kindt TJ. Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320 [Abstract] [Full Text] [Related]
6. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia. Kozako T, Fukada K, Hirata S, White Y, Harao M, Nishimura Y, Kino Y, Soeda S, Shimeno H, Lemonnier F, Sonoda S, Arima N. Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459 [Abstract] [Full Text] [Related]
7. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers. Akimoto M, Kozako T, Sawada T, Matsushita K, Ozaki A, Hamada H, Kawada H, Yoshimitsu M, Tokunaga M, Haraguchi K, Uozumi K, Arima N, Tei C. J Med Virol; 2007 Jul; 79(7):977-86. PubMed ID: 17516523 [Abstract] [Full Text] [Related]
8. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins. Kurihara K, Shimizu Y, Takamori A, Harashima N, Noji M, Masuda T, Utsunomiya A, Okamura J, Kannagi M. J Immunol Methods; 2006 Jun 30; 313(1-2):61-73. PubMed ID: 16723135 [Abstract] [Full Text] [Related]
9. [Anti-tumor immunity in adult T-cell leukemia]. Kannagi M. Uirusu; 2004 Jun 30; 54(1):67-74. PubMed ID: 15449906 [Abstract] [Full Text] [Related]
10. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation. Tanaka Y, Nakasone H, Yamazaki R, Wada H, Ishihara Y, Kawamura K, Sakamoto K, Ashizawa M, Machishima T, Sato M, Terasako K, Kimura S, Kikuchi M, Okuda S, Kako S, Kanda J, Tanihara A, Nishida J, Kanda Y. J Clin Immunol; 2012 Dec 30; 32(6):1340-52. PubMed ID: 22763862 [Abstract] [Full Text] [Related]
11. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax. Takatsuka N, Hasegawa A, Takamori A, Shimizu Y, Kato H, Ohashi T, Amagasa T, Masuda T, Kannagi M. Int Immunol; 2009 Sep 30; 21(9):1089-100. PubMed ID: 19654198 [Abstract] [Full Text] [Related]
12. Tumor immunity against adult T-cell leukemia. Kannagi M, Harashima N, Kurihara K, Ohashi T, Utsunomiya A, Tanosaki R, Masuda M, Tomonaga M, Okamura J. Cancer Sci; 2005 May 30; 96(5):249-55. PubMed ID: 15904464 [Abstract] [Full Text] [Related]
13. NF-kappaB in pathogenesis and treatment of adult T-cell leukemia/lymphoma. Horie R. Int Rev Immunol; 2007 May 30; 26(5-6):269-81. PubMed ID: 18027201 [Abstract] [Full Text] [Related]
14. [Natural history of human T-lymphotropic virus type 1 (HTLV-1) infection]. Okayama A. Rinsho Byori; 2005 Sep 30; 53(9):837-44. PubMed ID: 16235837 [Abstract] [Full Text] [Related]
15. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL]. Tanaka Y, Kanda Y. Rinsho Ketsueki; 2015 Jul 30; 56(7):815-24. PubMed ID: 26251144 [Abstract] [Full Text] [Related]
16. Identification of two new HLA-A*1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. Harashima N, Tanosaki R, Shimizu Y, Kurihara K, Masuda T, Okamura J, Kannagi M. J Virol; 2005 Aug 30; 79(15):10088-92. PubMed ID: 16014972 [Abstract] [Full Text] [Related]
17. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types. Amano M, Kurokawa M, Ogata K, Itoh H, Kataoka H, Setoyama M. J Dermatol; 2008 May 30; 35(5):270-5. PubMed ID: 18477226 [Abstract] [Full Text] [Related]
18. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry. Lee TH, Chafets DM, Busch MP, Murphy EL. J Clin Virol; 2004 Dec 30; 31(4):275-82. PubMed ID: 15494269 [Abstract] [Full Text] [Related]